Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma ; volume:51 ; number:4 ; day:20 ; month:11 ; year:2023 ; pages:1085-1096 ; date:3.2024
European journal of nuclear medicine and molecular imaging ; 51, Heft 4 (20.11.2023), 1085-1096, 3.2024

Classification: Medizin, Gesundheit

Creator: Lai, Thu Hang
Wenzel, Barbara
Dukić-Stefanović, Sladjana
Teodoro, Rodrigo
Arnaud, Lucie
Maisonial-Besset, Aurélie
Weber, Valérie
Moldovan, Rareş-Petru
Meister, Sebastian
Pietzsch, Jens
Kopka, Klaus
Juratli, Tareq
Deuther-Conrad, Winnie
Toussaint, Magali

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00259-023-06515-7

URN: urn:nbn:de:101:1-2404291353146.744133284809

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 2025-08-14T10:56:03+0200

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lai, Thu Hang
Wenzel, Barbara
Dukić-Stefanović, Sladjana
Teodoro, Rodrigo
Arnaud, Lucie
Maisonial-Besset, Aurélie
Weber, Valérie
Moldovan, Rareş-Petru
Meister, Sebastian
Pietzsch, Jens
Kopka, Klaus
Juratli, Tareq
Deuther-Conrad, Winnie
Toussaint, Magali
SpringerLink (Online service)

Other Objects (12)

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Hochschulschrift

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Hochschulschrift

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Hochschulschrift

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma

Synthesis and evaluation of 18F-labeled inhibitors for targeting mutant isocitrate dehydrogenase 1 (mIDH1)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

[18F]Fluorocholine PET/CT false positive: foreign body reaction mimicking anaplastic glioma progression. A case report

Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Immunologische Untersuchungen zur Charakterisierung von Pyruvatkinase- und Glucose-6-phosphat-Dehydrogenase-Mutanten [Glucose-phosphat-Dehydrogenase-Mutanten] roter Blutzellen des Menschen

Related objects

Reset password